This 2020 study by Wang et al. analyzed data from the Long Island Breast Cancer Study Project to assess the association between menopausal hormone therapy (MHT) use and long-term mortality outcomes. Among women with breast cancer, ever-users of MHT had a 23% lower risk of all-cause mortality (HR=0.77), a 31%